Bernhard Sixt is an accomplished healthcare consultant and leader with extensive experience in the biotechnology and medical diagnostics sectors. Currently serving as Chairman Of The Board at Ipotuba and as a consultant for healthcare at Dr. Sixt Consulting, Bernhard focuses on strategic consulting and the execution of business plans within the industry. Bernhard has held significant leadership roles, including CEO of Edinburgh Molecular Imaging Ltd, which specializes in real-time disease detection, and ImmunID, a pioneer in molecular immune diagnostics. As a co-founder, President, and CEO of Agendia, Bernhard contributed to the development of innovative genomic diagnostic products for breast cancer. Previous positions include director roles at Amersham Health and Nycomed, complementing an academic background with a Ph.D. in Biochemistry from the Technical University of Munich and a Master's degree in Chemistry and Biochemistry from Ludwig-Maximilians-Universität München.
Org chart
This person is not in the org chart
Teams
This person is not in any teams
